Testing a new drug for schizophrenia with acute symptoms
Part of Mental health clinical trials.
This trial tests if LY03020 helps people with schizophrenia who are currently having a severe episode. If you have acute symptoms like hallucinations or delusions, this study could be an option.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 65 years old.
- You have a diagnosis of schizophrenia and are currently in a severe episode that requires hospitalization.
- Your symptoms include at least two of the following: delusions, disorganized thinking, hallucinations, or suspiciousness, and they are moderate or worse.
- You have not taken certain other psychiatric medications recently or have not responded to clozapine before.
- You do not have certain heart problems, eye conditions, or a history of suicide attempts or severe suicidal thoughts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests the safety of a new medication called LY03020. It is for healthy volunteers and for people with stable schizophrenia. The study aims to see how well the body handles the drug and what side effects might occur.
This trial tests a new medication called VV119 for adults currently experiencing a sudden worsening of schizophrenia symptoms. The goal is to see if it is safe and if it helps reduce symptoms like delusions, disorganized thinking, and hallucinations.
This trial tests a new medication called LB-102 for people with acute (sudden worsening of) schizophrenia. It aims to see if the drug helps reduce symptoms like hallucinations or disorganized thinking.
This trial tests a new medication called SEP-363856 for people with schizophrenia who are currently having a severe flare-up of symptoms. It aims to see if the drug is safe and effective compared to a placebo.
This trial tests an experimental medicine, LTX-001, for people with schizophrenia who are currently having a sudden worsening of symptoms. It aims to see if the drug can help reduce these acute symptoms.
This study tests an experimental medication called QLM1016 for people with schizophrenia. It aims to see if the drug helps reduce symptoms like delusions, hallucinations, and disorganized thinking.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.